Rockwell Automation, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +75

Rockwell Automation Announces the Advance of Rovi Pharmaceutical Manufacturing Digitalization | Corporate - EQS News

AI-generated analysis

🏭 Laboratorios Farmacéuticos Rovi successfully implemented a comprehensive digital batch execution system with Rockwell Automation and Adasoft.

📅 The first phase of the project was completed in under one year, removing paper documentation from Rovi's manufacturing processes.

🔗 FactoryTalk PharmaSuite MES was integrated with core business platforms including ERP and LIMS to improve traceability.

✅ Key outcomes include reduced review times, enhanced competitiveness, and improved data integrity for the pharmaceutical manufacturer.

🤝 Adasoft served as a Gold-level system integrator, ensuring seamless integration within Rockwell Automation's PartnerNetwork ecosystem.

🚀 The successful standard approach lays the foundation for future digital rollouts across additional Rovi facilities.

🎓 Rockwell provided full lifecycle support including design, software licensing, recipe creation, and staff training.

💼 Rodrigo Riera of Rockwell noted that the results set a new benchmark for the industry in pharmaceutical manufacturing.

🌐 The project aligns with Rockwell Automation's mission to help customers become more competitive and sustainable.

Bullish Signals
  • Rovi has achieved rapid, tangible results by removing paper-based records and fully digitalizing batch execution processes.
  • The integration of FactoryTalk PharmaSuite MES with ERP and LIMS has improved traceability and reduced review times.
  • The project was completed in under a year, demonstrating an efficient implementation timeline for such a complex transformation.
  • Rockwell Automation's support covered the entire lifecycle from design to validation, ensuring high standards in regulated environments.
  • Adasoft's role as a Gold-level integrator ensured seamless delivery and smooth transition to a fully digital environment.
  • The standard and replicable approach adopted creates a scalable foundation for future rollouts across Rovi's other facilities.
  • The initiative enhances Rovi's competitiveness and aligns with industry goals for operational excellence and data integrity.
Full Analysis
Rockwell Automation announced that Laboratorios Farmacéuticos Rovi, S.A., a leading specialty pharmaceutical company, has successfully implemented a comprehensive digital batch execution system. This initiative was executed in collaboration with Rockwell Automation and Adasoft, an engineering integrator, marking a significant milestone in Rovi's journey toward operational excellence and data integrity. The project focused on fully digitalizing batch execution processes by removing paper-based records and integrating Rockwell's FactoryTalk PharmaSuite manufacturing execution system (MES) with core business platforms like ERP and LIMS. The first phase was completed in under a year, resulting in the removal of paper documentation, improved traceability, reduced review times, and enhanced competitiveness for Rovi. Rockwell Automation supported Rovi throughout the project lifecycle, from design and software licensing to recipe creation, project management, staff training, and system validation. The standard approach adopted for this initial implementation has laid the foundation for future rollouts across additional Rovi facilities, aligning with Rockwell's mission to help customers become more competitive, resilient, and sustainable. Adasoft played a critical role as a Gold-level system integrator in Rockwell Automation's PartnerNetwork ecosystem, ensuring seamless integration and project delivery. Both companies plan to continue their collaboration to advance digital transformation and process automation across Rovi's operations, leveraging Rockwell's experience in regulated environments.